Showing results (1-10 of 190) with videos related to
Sort By:
Pageof 19
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|October 21, 2023
Families with non-Hodgkin lymphoma and plasma cell dyscrasias in their pedigreesPeter H Wiernik, Janice P DutcherClinical Advances in Hematology & Oncology : H&O|September 10, 2015
Renal cell carcinoma in patients with a personal or family history of hematologic malignanciesJanice P Dutcher, Peter H WiernikAmerican Journal of Hematology|March 22, 2006
Renal parenchymal tumors and lymphoma in the same patient: case series and review of the literatureAnuradha Kunthur, Peter H Wiernik, Janice P DutcherClinical Advances in Hematology & Oncology : H&O|September 10, 2015
Families with both Hodgkin lymphoma and multiple myeloma in their pedigreesPeter H Wiernik, Dona Wickramasinghe, Janice P DutcherJournal of Investigative Medicine High Impact Case Reports|May 5, 2016
Pure Red Cell Aplasia Following Interleukin-2 TherapyJanice P Dutcher, Wen Fan, Peter H WiernikMedical Oncology (Northwood, London, England)|June 21, 2005
Metastatic melanoma: is biochemotherapy the future?Doru T Alexandrescu, Janice P Dutcher, Peter H WiernikJournal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|June 13, 2024
Families with multiple individuals with acute leukemia in their pedigreesPeter H Wiernik, Matthew P Blakley, Janice P DutcherLeukemia Research|February 12, 2018
Pulmonary Langerhans cell histiocytosis, acute myeloid leukemia, and myelofibrosis in a large family and review of the literatureMatthew P Blakley, Janice P Dutcher, Peter H WiernikFamilial Cancer|June 24, 2016
Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in familiesJanice P Dutcher, Peter H Wiernik, Leticia Varella, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2005
Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome associated with high-dose interleukin-2 for the treatment of metastatic melanomaDoru T Alexandrescu, Prasad Maddukuri, Peter H Wiernik, et al.Pageof 19